RT Journal Article
SR Electronic
T1 Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.10.20021675
DO 10.1101/2020.02.10.20021675
A1 Yang, Yang
A1 Lu, Qing-Bin
A1 Liu, Ming-Jin
A1 Wang, Yi-Xing
A1 Zhang, An-Ran
A1 Jalali, Neda
A1 Dean, Natalie E.
A1 Longini, Ira
A1 Halloran, M. Elizabeth
A1 Xu, Bo
A1 Zhang, Xiao-Ai
A1 Wang, Li-Ping
A1 Liu, Wei
A1 Fang, Li-Qun
YR 2020
UL http://medrxiv.org/content/early/2020/02/21/2020.02.10.20021675.abstract
AB Our manuscript was based on surveillance cases of COVID-19 identified before January 26, 2020. As of February 20, 2020, the total number of confirmed cases in mainland China has reached 18 times of the number in our manuscript. While the methods and the main conclusions in our original analyses remain solid, we decided to withdraw this preprint for the time being, and will replace it with a more up-to-date version shortly. Should you have any comments or suggestions, please feel free to contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was financially supported by grants from the China Mega-Project on Infectious Disease Prevention (No. 2018ZX10713001, 2018ZX10713002, 2017ZX10103004 and 2018ZX10101003-002), the National Natural Science Funds (No. 81825019), and the U.S. National Institute of Health (R01 AI139761 and R01 AI116770).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes